Provides a clinical overview of the evaluation and management of atrial fibrillation in young, active patients and athletes.
Answers are grounded in this paper and cite their sources.
May guide AF evaluation in athletes; leaves open need for prospective trials in this population.
Atrial fibrillation in young or middle-aged active patients can often be managed with medication. Evaluation should address associated conditions and predisposing factors such as idiopathic hypertrophic subaortic stenosis, Wolff-Parkinson-White syndrome, congenital heart disease, hyperthyroidism, excess alcohol or other drug use, and exercise-induced catecholamine release. Diagnostic studies may include an ECG, 24-hour Holter or event monitoring, exercise treadmill testing, stress echocardiography, electrophysiologic studies, and laboratory testing. Electrocardioversion provides rapid, predictable treatment, but ablation therapy is sometimes needed.
No takes yet. Share an insight, caveat, or question.
Reiss et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: